黃柏揚 (2004). 基質細胞對小鼠子宮內骨髓移植之植入率的評估. 輔仁大學生命科學所碩士論文呂昀 (2005). IL-10培養之樹突狀細胞對小鼠子宮內骨髓移植效用之評估. 輔仁大學生命科學所碩士論文孫子麒 (2007). 免疫抑制型細胞激素培養之樹突狀細胞對胎鼠骨髓移植之效用評估 . 輔仁大學生命科學所碩士論文Ahuja, S. S., Paliogianni, F., Yamada, H., Balow, J. E. & Boumpas, D. T. 1993. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol 150:3109-18.
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. & Palucka, K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
Banchereau, J. & Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245-52.
Bhattacharyya, S. & Cowan, M. J. 2005. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 11:657-71.
Billingham, R. E. & Brent, L. 1957. A simple method for inducing tolerance of skin homografts in mice. Transplant Bull 4:67-71.
Bogdan, C. & Nathan, C. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685:713-39.
Breckpot, K., Dullaers, M., Bonehill, A., van Meirvenne, S., Heirman, C., de Greef, C., van der Bruggen, P. & Thielemans, K. 2003. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gene Med 5:654-67.
Brocker, T., Riedinger, M. & Karjalainen, K. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 185:541-50.
Buckley, R. H. 2003. 27. Transplantation immunology: organ and bone marrow. J Allergy Clin Immunol 111:S733-44.
Bushman, F. D. & Craigie, R. 1991. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A 88:1339-43.
Cheifetz, S., Weatherbee, J. A., Tsang, M. L., Anderson, J. K., Mole, J. E., Lucas, R. & Massague, J. 1987. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409-15.
Chen, W., Sayegh, M. H. & Khoury, S. J. 1998. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J Immunol 160:1504-8.
Cheng, J., Xia, S. S., Xie, S., Tang, L. G. & Shi, X. F. 2005. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance. Transplant Proc 37:2360-4.
Chinnasamy, D., Chinnasamy, N., Enriquez, M. J., Otsu, M., Morgan, R. A. & Candotti, F. 2000. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96:1309-16.
Chou, S. H., Chawla, A., Lee, T. H., Zhou, Y., Busch, M. P., Balassanian, R., Ferrell, L. & Cowan, M. J. 2001. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model. Transplantation 72:1768-76.
Cohen, E. A., Terwilliger, E. F., Jalinoos, Y., Proulx, J., Sodroski, J. G. & Haseltine, W. A. 1990. Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr 3:11-8.
Cowan, M. J. 1991. Bone marrow transplantation for the treatment of genetic diseases. Clin Biochem 24:375-81.
Cullen, B. R. 1991. Regulation of gene expression in the human immunodeficiency virus type 1. Adv Virus Res 40:1-17.
Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H., Greaves, M. F. & Weiss, R. A. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-7.
Danzer, S. G., Kirchner, H. & Rink, L. 1994. Cytokine interactions in human mixed lymphocyte culture. Transplantation 57:1638-42.
Das, A. T., Koken, S. E., Essink, B. B., van Wamel, J. L. & Berkhout, B. 1994. Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells. FEBS Lett 341:49-53.
David, A., Chetritt, J., Guillot, C., Tesson, L., Heslan, J. M., Cuturi, M. C., Soulillou, J. P. & Anegon, I. 2000. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther 7:505-10.
Davoust, J. & Banchereau, J. 2000. Naked antigen-presenting molecules on dendritic cells. Nat Cell Biol 2:E46-8.
De Palma, M., Montini, E., Santoni de Sio, F. R., Benedicenti, F., Gentile, A., Medico, E. & Naldini, L. 2005. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105:2307-15.
De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O. & Moser, M. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413-24.
DeBruyne, L. A., Li, K., Chan, S. Y., Qin, L., Bishop, D. K. & Bromberg, J. S. 1998. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther 5:1079-87.
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R. & Romagnani, S. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-60.
Demetris, A. J., Murase, N., Ye, Q., Galvao, F. H., Richert, C., Saad, R., Pham, S., Duquesnoy, R. J., Zeevi, A., Fung, J. J. & Starzl, T. E. 1997. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 150:563-78.
den Haan, J. M., Sherman, N. E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J. W., Skipper, J., Shabanowitz, J., Hunt, D. F., Engelhard, V. H. & et al. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476-80.
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B. & Goeddel, D. V. 1985. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-5.
Derynck, R., Lindquist, P. B., Lee, A., Wen, D., Tamm, J., Graycar, J. L., Rhee, L., Mason, A. J., Miller, D. A., Coffey, R. J. & et al. 1988. A new type of transforming growth factor-beta, TGF-beta 3. Embo J 7:3737-43.
Derynck, R., Rhee, L., Chen, E. Y. & Van Tilburg, A. 1987. Intron-exon structure of the human transforming growth factor-beta precursor gene. Nucleic Acids Res 15:3188-9.
Doney, K. C., Weiden, P. L., Storb, R. & Thomas, E. D. 1981. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1-8.
Dorshkind, K. 1990. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-37.
DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H. & Calos, M. P. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7:379-87.
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D. & Naldini, L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-71.
Enk, A. H., Angeloni, V. L., Udey, M. C. & Katz, S. I. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151:2390-8.
Fairchild, P. J. & Waldmann, H. 2000. Dendritic cells and prospects for transplantation tolerance. Curr Opin Immunol 12:528-35.
Fernandes, J. R., Duvivier-Kali, V. F., Keegan, M., Hollister-Lock, J., Omer, A., Su, S., Bonner-Weir, S., Feng, S., Lee, J. S., Mulligan, R. C. & Weir, G. C. 2004. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Transpl Immunol 13:191-200.
Fiorentino, D. F., Bond, M. W. & Mosmann, T. R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-95.
Firat, H., Zennou, V., Garcia-Pons, F., Ginhoux, F., Cochet, M., Danos, O., Lemonnier, F. A., Langlade-Demoyen, P. & Charneau, P. 2002. Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med 4:38-45.
Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J. & Moser, M. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24:605-10.
Follenzi, A. & Gupta, S. 2004. The promise of lentiviral gene therapy for liver cancer. J Hepatol 40:337-40.
Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C. & Naldini, L. 2002. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther 13:243-60.
Fu, F., Li, Y., Qian, S., Lu, L., Chambers, F., Starzl, T. E., Fung, J. J. & Thomson, A. W. 1996. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659-65.
Gammie, J. S. & Pham, S. M. 1999. Simultaneous donor bone marrow and cardiac transplantation: can tolerance be induced with the development of chimerism? Curr Opin Cardiol 14:126-32.
Gasmi, M., Glynn, J., Jin, M. J., Jolly, D. J., Yee, J. K. & Chen, S. T. 1999. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol 73:1828-34.
Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O. & Durandy, A. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 162:4567-75.
Goff, S. P. 1990. Retroviral reverse transcriptase: synthesis, structure, and function. J Acquir Immune Defic Syndr 3:817-31.
Good, R. A. & Verjee, T. 2001. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Blood Marrow Transplant 7:123-35.
Gorski, K. S., Shin, T., Crafton, E., Otsuji, M., Rattis, F. M., Huang, X., Kelleher, E., Francisco, L., Pardoll, D. & Tsuchiya, H. 2003. A set of genes selectively expressed in murine dendritic cells: utility of related cis-acting sequences for lentiviral gene transfer. Mol Immunol 40:35-47.
Grouard, G., Durand, I., Filgueira, L., Banchereau, J. & Liu, Y. J. 1996. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384:364-7.
Groux, H., Bigler, M., de Vries, J. E. & Roncarolo, M. G. 1998. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 160:3188-93.
Hamaguchi, I., Woods, N. B., Panagopoulos, I., Andersson, E., Mikkola, H., Fahlman, C., Zufferey, R., Carlsson, L., Trono, D. & Karlsson, S. 2000. Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol 74:10778-84.
Hancock, G. E., Cohn, Z. A. & Kaplan, G. 1989. The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J Exp Med 169:909-19.
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F. & Wood, K. J. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166:3789-96.
Hashimoto, F., Sugiura, K., Inoue, K. & Ikehara, S. 1997. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 89:49-54.
Hempel, L., Korholz, D., Nussbaum, P., Bonig, H., Burdach, S. & Zintl, F. 1997. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant 20:365-8.
Hisha, H., Nishino, T., Kawamura, M., Adachi, S. & Ikehara, S. 1995. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 23:347-52.
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P. & O'Keeffe, M. 2001. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166:5448-55.
Holder, M. J., Knox, K. & Gordon, J. 1992. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur J Immunol 22:2725-8.
Hurley, C. K., Wade, J. A., Oudshoorn, M., Middleton, D., Kukuruga, D., Navarrete, C., Christiansen, F., Hegland, J., Ren, E. C., Andersen, I., Cleaver, S. A., Brautbar, C. & Raffoux, C. 1999. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Bone Marrow Transplant 24:119-21.
Illidge, T. M. & Johnson, P. W. 2000. The emerging role of radioimmunotherapy in haematological malignancies. Br J Haematol 108:679-88.
Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Reis e Sousa, C., Germain, R. N., Mellman, I. & Steinman, R. M. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 191:927-36.
Ishida, T., Inaba, M., Hisha, H., Sugiura, K., Adachi, Y., Nagata, N., Ogawa, R., Good, R. A. & Ikehara, S. 1994. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119-27.
Jin, Y. X., Xu, L. Y., Guo, H., Ishikawa, M., Link, H. & Xiao, B. G. 2000. TGF-beta1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells. J Autoimmun 14:213-20.
Jonuleit, H., Tuting, T., Steitz, J., Bruck, J., Giesecke, A., Steinbrink, K., Knop, J. & Enk, A. H. 2000. Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther 7:249-54.
Kafri, T., van Praag, H., Ouyang, L., Gage, F. H. & Verma, I. M. 1999. A packaging cell line for lentivirus vectors. J Virol 73:576-84.
Kalinski, P., Hilkens, C. M., Wierenga, E. A. & Kapsenberg, M. L. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 20:561-7.
Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B. & Fauci, A. S. 1986. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855-60.
Kelsall, B. L. & Leon, F. 2005. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 206:132-48.
Kim, J. M., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Khan, T. A. & Moore, K. W. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148:3618-23.
Kim, S. E., Lee, J. H., Choi, S. J., Lee, J. H., Ryu, S. G. & Lee, K. H. 2005. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan. Haematologica 90:285-6.
Kim, Y. S., Lim, H. K. & Kim, K. J. 1998. Production of high-titer retroviral vectors and detection of replication-competent retroviruses. Mol Cells 8:36-42.
Kondaiah, P., Sands, M. J., Smith, J. M., Fields, A., Roberts, A. B., Sporn, M. B. & Melton, D. A. 1990. Identification of a novel transforming growth factor-beta (TGF-beta 5) mRNA in Xenopus laevis. J Biol Chem 265:1089-93.
Kordower, J. H., Bloch, J., Ma, S. Y., Chu, Y., Palfi, S., Roitberg, B. Z., Emborg, M., Hantraye, P., Deglon, N. & Aebischer, P. 1999. Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160:1-16.
Koshiba, T., Kitade, H., Waer, M., Mathieu, C., Van Damme, B. & Pirenne, J. 2003. Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation. Transplant Proc 35:3153-5.
Krieger, N. R., Yin, D. P. & Fathman, C. G. 1996. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 184:2013-8.
Kronin, V., Winkel, K., Suss, G., Kelso, A., Heath, W., Kirberg, J., von Boehmer, H. & Shortman, K. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol 157:3819-27.
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-74.
Kulkarni, A. B., Thyagarajan, T. & Letterio, J. J. 2002. Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2:303-27.
Kurtz, J., Shaffer, J., Lie, A., Anosova, N., Benichou, G. & Sykes, M. 2004. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Blood 103:4336-43.
Lanzavecchia, A. & Sallusto, F. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13:291-8.
Lechler, R., Ng, W. F. & Steinman, R. M. 2001. Dendritic cells in transplantation--friend or foe? Immunity 14:357-68.
Lee, W. C., Zhong, C., Qian, S., Wan, Y., Gauldie, J., Mi, Z., Robbins, P. D., Thomson, A. W. & Lu, L. 1998. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta. Transplantation 66:1810-7.
Letterio, J. J. & Roberts, A. B. 1998. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137-61.
Lever, A., Gottlinger, H., Haseltine, W. & Sodroski, J. 1989. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 63:4085-7.
Lewis, P., Hensel, M. & Emerman, M. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. Embo J 11:3053-8.
Lewis, P. F. & Emerman, M. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510-6.
Li, W., Fu, F., Lu, L., Narula, S. K., Fung, J. J., Thomson, A. W. & Qian, S. 1999. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation 68:1402-9.
Lin, Y., Vandeputte, M. & Waer, M. 1997. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 158:5658-67.
Liu, H., Wu, X., Newman, M., Shaw, G. M., Hahn, B. H. & Kappes, J. C. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol 69:7630-8.
Lois, C., Hong, E. J., Pease, S., Brown, E. J. & Baltimore, D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-72.
Lomo, J., Blomhoff, H. K., Beiske, K., Stokke, T. & Smeland, E. B. 1995. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 154:1634-43.
Long, E. & Wood, K. J. 2007. Understanding FOXP3: progress towards achieving transplantation tolerance. Transplantation 84:459-61.
Lu, L., Li, W., Fu, F., Chambers, F. G., Qian, S., Fung, J. J. & Thomson, A. W. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808-15.
Lu, L. & Thomson, A. W. 2002. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 73:S19-22.
Ludewig, B., Oehen, S., Barchiesi, F., Schwendener, R. A., Hengartner, H. & Zinkernagel, R. M. 1999. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J Immunol 163:1839-44.
Luo, X., Tarbell, K. V., Yang, H., Pothoven, K., Bailey, S. L., Ding, R., Steinman, R. M. & Suthanthiran, M. 2007. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104:2821-6.
Lutz, M. B. & Schuler, G. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23:445-9.
Lutz, M. B., Suri, R. M., Niimi, M., Ogilvie, A. L., Kukutsch, N. A., Rossner, S., Schuler, G. & Austyn, J. M. 2000. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813-22.
MacDonald, K. P., Rowe, V., Clouston, A. D., Welply, J. K., Kuns, R. D., Ferrara, J. L., Thomas, R. & Hill, G. R. 2005. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol 174:1841-50.
Mackey, M. F., Gunn, J. R., Maliszewsky, C., Kikutani, H., Noelle, R. J. & Barth, R. J., Jr. 1998. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161:2094-8.
Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A. & Axel, R. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-48.
Madrenas, J., Schwartz, R. H. & Germain, R. N. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc Natl Acad Sci U S A 93:9736-41.
Manganini, M., Serafini, M., Bambacioni, F., Casati, C., Erba, E., Follenzi, A., Naldini, L., Bernasconi, S., Gaipa, G., Rambaldi, A., Biondi, A., Golay, J. & Introna, M. 2002. A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther 13:1793-807.
Martin, P. J., Hansen, J. A., Storb, R. & Thomas, E. D. 1987. Human marrow transplantation: an immunological perspective. Adv Immunol 40:379-438.
Massague, J. 1987. The TGF-beta family of growth and differentiation factors. Cell 49:437-8.
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G. & Kiessling, R. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-6.
Matthews, D. C., Appelbaum, F. R., Eary, J. F., Fisher, D. R., Durack, L. D., Hui, T. E., Martin, P. J., Mitchell, D., Press, O. W., Storb, R. & Bernstein, I. D. 1999. Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome. Blood 94:1237-47.
McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L. & Wahl, S. 1990. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 4:27-35.
Mervis, R. J., Ahmad, N., Lillehoj, E. P., Raum, M. G., Salazar, F. H., Chan, H. W. & Venkatesan, S. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J Virol 62:3993-4002.
Miller, D. G., Adam, M. A. & Miller, A. D. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-42.
Min, W. P., Gorczynski, R., Huang, X. Y., Kushida, M., Kim, P., Obataki, M., Lei, J., Suri, R. M. & Cattral, M. S. 2000. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 164:161-7.
Mittl, P. R., Priestle, J. P., Cox, D. A., McMaster, G., Cerletti, N. & Grutter, M. G. 1996. The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci 5:1261-71.
Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. & Verma, I. M. 1998. Development of a self-inactivating lentivirus vector. J Virol 72:8150-7.
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M. & Torbett, B. E. 1999. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-6.
Miyoshi, H., Takahashi, M., Gage, F. H. & Verma, I. M. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A 94:10319-23.
Mou, H. B., Lin, M. F., Cen, H., Huang, H. & Cai, Z. 2004a. Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells. Transplant Proc 36:1604-6.
Mou, H. B., Lin, M. F., Cen, H., Yu, J. & Meng, X. J. 2004b. TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression. J Zhejiang Univ Sci 5:1239-44.
Muller-Sieburg, C. E. & Deryugina, E. 1995. The stromal cells' guide to the stem cell universe. Stem Cells 13:477-86.
Naldini, L., Blomer, U., Gage, F. H., Trono, D. & Verma, I. M. 1996a. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93:11382-8.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M. & Trono, D. 1996b. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-7.
Nguyen, T. H., Oberholzer, J., Birraux, J., Majno, P., Morel, P. & Trono, D. 2002. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 6:199-209.
Niiro, H., Otsuka, T., Kuga, S., Nemoto, Y., Abe, M., Hara, N., Nakano, T., Ogo, T. & Niho, Y. 1994. IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int Immunol 6:661-4.
Noort, W. A., Kruisselbrink, A. B., in't Anker, P. S., Kruger, M., van Bezooijen, R. L., de Paus, R. A., Heemskerk, M. H., Lowik, C. W., Falkenburg, J. H., Willemze, R. & Fibbe, W. E. 2002. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30:870-8.
O'Rourke, R. W., Kang, S. M., Lower, J. A., Feng, S., Ascher, N. L., Baekkeskov, S. & Stock, P. G. 2000. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation 69:1440-6.
Ogawa, H., Soma, T., Hosen, N., Tatekawa, T., Tsuboi, A., Oji, Y., Tamaki, H., Kawakami, M., Ikegame, K., Murakami, M., Fujioka, T., Kim, E. H., Oka, Y. & Sugiyama, H. 2002. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Transplantation 74:236-43.
Ohteki, T., Fukao, T., Suzue, K., Maki, C., Ito, M., Nakamura, M. & Koyasu, S. 1999. Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med 189:1981-6.
Opelz, G. 1995. Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative Transplant Study. Transplantation 60:1220-4.
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., Humphries, R. K., Beuzard, Y., Nagel, R. L. & Leboulch, P. 2001. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 294:2368-71.
Peguet-Navarro, J., Moulon, C., Caux, C., Dalbiez-Gauthier, C., Banchereau, J. & Schmitt, D. 1994. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 24:884-91.
Peng, C., Ho, B. K., Chang, T. W. & Chang, N. T. 1989. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 63:2550-6.
Penna, G. & Adorini, L. 2000. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-11.
Pfeifer, A., Ikawa, M., Dayn, Y. & Verma, I. M. 2002. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A 99:2140-5.
Pistoia, V. 1997. Production of cytokines by human B cells in health and disease. Immunol Today 18:343-50.
Pooley, J. L., Heath, W. R. & Shortman, K. 2001. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 166:5327-30.
Prockop, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-4.
Przepiorka, D., Kernan, N. A., Ippoliti, C., Papadopoulos, E. B., Giralt, S., Khouri, I., Lu, J. G., Gajewski, J., Durett, A., Cleary, K., Champlin, R., Andersson, B. S. & Light, S. 2000. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 95:83-9.
Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E. & Maliszewski, C. R. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96:1036-41.
Qin, L., Chavin, K. D., Ding, Y., Favaro, J. P., Woodward, J. E., Lin, J., Tahara, H., Robbins, P., Shaked, A., Ho, D. Y. & et al. 1995. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation 59:809-16.
Qin, L., Ding, Y., Pahud, D. R., Robson, N. D., Shaked, A. & Bromberg, J. S. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8:1365-74.
Ranges, G. E., Figari, I. S., Espevik, T. & Palladino, M. A., Jr. 1987. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166:991-8.
Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H., Melief, C. J. & Offringa, R. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95:3162-7.
Reid, S. D., Penna, G. & Adorini, L. 2000. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol 12:114-21.
Roberts, A. B., Lamb, L. C., Newton, D. L., Sporn, M. B., De Larco, J. E. & Todaro, G. J. 1980. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A 77:3494-8.
Rock, K. L. & Clark, K. 1996. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J Immunol 156:3721-6.
Rose, D. M., Fadok, V. A., Riches, D. W., Clay, K. L. & Henson, P. M. 1995. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. J Immunol 155:5819-25.
Rossini, A. A., Greiner, D. L. & Mordes, J. P. 1999. Induction of immunologic tolerance for transplantation. Physiol Rev 79:99-141.
Rouas, R., Uch, R., Cleuter, Y., Jordier, F., Bagnis, C., Mannoni, P., Lewalle, P., Martiat, P. & Van den Broeke, A. 2002. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9:715-24.
Rutella, S., Danese, S. & Leone, G. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435-40.
Saas, P. & Tiberghien, P. 2002. Dendritic cells: to where do they lead? Transplantation 73:S12-5.
Sad, S. & Mosmann, T. R. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 153:3514-22.
Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-62.
Salmon, P., Arrighi, J. F., Piguet, V., Chapuis, B., Zubler, R. H., Trono, D. & Kindler, V. 2001. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells. J Gene Med 3:311-20.
Sayegh, M. H. & Carpenter, C. B. 1996. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 13:221-9.
Schlegel, R., Tralka, T. S., Willingham, M. C. & Pastan, I. 1983. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32:639-46.
Schuurhuis, D. H., Laban, S., Toes, R. E., Ricciardi-Castagnoli, P., Kleijmeer, M. J., van der Voort, E. I., Rea, D., Offringa, R., Geuze, H. J., Melief, C. J. & Ossendorp, F. 2000. Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med 192:145-50.
Seyedin, S. M., Segarini, P. R., Rosen, D. M., Thompson, A. Y., Bentz, H. & Graycar, J. 1987. Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta. J Biol Chem 262:1946-9.
Shortman, K. & Liu, Y. J. 2002. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-61.
Sirven, A., Pflumio, F., Zennou, V., Titeux, M., Vainchenker, W., Coulombel, L., Dubart-Kupperschmitt, A. & Charneau, P. 2000. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96:4103-10.
Skipper, H. E. 1964. Perspectives in Cancer Chemotherapy: Therapeutic Design. Cancer Res 24:1295-302.
Sporn, M. B. & Roberts, A. B. 1990. The transforming growth factor-betas: past, present, and future. Ann N Y Acad Sci 593:1-6.
Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G. & Engleman, E. G. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659-68.
Steinman, R. & Inaba, K. 1989. Immunogenicity: role of dendritic cells. Bioessays 10:145-52.
Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-96.
Steinman, R. M. 2003. The control of immunity and tolerance by dendritic cell. Pathol Biol (Paris) 51:59-60.
Steinman, R. M. & Cohn, Z. A. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142-62.
Sun, P. D. & Davies, D. R. 1995. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct 24:269-91.
Suthanthiran, M. & Strom, T. B. 1998. Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 78:77-94.
Swain, S. L., Huston, G., Tonkonogy, S. & Weinberg, A. 1991. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 147:2991-3000.
Sykes, M. 1996. Hematopoietic cell transplantation for the induction of allo- and xenotolerance. Clin Transplant 10:357-63.
Takayama, T., Kaneko, K., Morelli, A. E., Li, W., Tahara, H. & Thomson, A. W. 2002. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation 74:112-9.
Takayama, T., Nishioka, Y., Lu, L., Lotze, M. T., Tahara, H. & Thomson, A. W. 1998. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66:1567-74.
te Velde, A. A., de Waal Malefijt, R., Huijbens, R. J., de Vries, J. E. & Figdor, C. G. 1992. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 149:4048-52.
Thery, C. & Amigorena, S. 2001. The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 13:45-51.
Thomson, A. W. & Lu, L. 1999. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68:1-8.
van Twuyver, E., Kast, W. M., Mooijaart, R. J., Melief, C. J. & De Waal, L. P. 1990. Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur J Immunol 20:441-4.
Vincenti, F., de Andres, A., Becker, T., Choukroun, G., Cole, E., Gonzalez-Posada, J. M., Kumar, M. A., Moore, R., Nadalin, S., Nashan, B., Rostaing, L., Saito, K. & Yoshimura, N. 2006. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int 19:446-57.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B. & Sporn, M. B. 1987. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84:5788-92.
Waldmann, H. 1999. Transplantation tolerance-where do we stand? Nat Med 5:1245-8.
Wekerle, T., Blaha, P., Langer, F., Schmid, M. & Muehlbacher, F. 2002. Tolerance through bone marrow transplantation with costimulation blockade. Transpl Immunol 9:125-33.
Wekerle, T. & Sykes, M. 2004. Induction of tolerance. Surgery 135:359-64.
Welch, G. R., Wong, H. L. & Wahl, S. M. 1990. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol 144:3444-8.
Whartenby, K. A., Straley, E. E., Kim, H., Racke, F., Tanavde, V., Gorski, K. S., Cheng, L., Pardoll, D. M. & Civin, C. I. 2002. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood 100:3147-54.
Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A. & Klausner, R. D. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A 85:9580-4.
Wiseman, D. M., Polverini, P. J., Kamp, D. W. & Leibovich, S. J. 1988. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157:793-800.
Wolfgang, M. J., Eisele, S. G., Browne, M. A., Schotzko, M. L., Garthwaite, M. A., Durning, M., Ramezani, A., Hawley, R. G., Thomson, J. A. & Golos, T. G. 2001. Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc Natl Acad Sci U S A 98:10728-32.
Wu, D. Y. & Goldschneider, I. 2001. Tolerance to cyclosporin A-induced autologous graft-versus-host disease is mediated by a CD4+CD25+ subset of recent thymic emigrants. J Immunol 166:7158-64.
Xu, K., Zhu, F., Du, B., Gao, F., Cheng, H. & Pan, X. 2008. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment. Transplant Proc 40:2665-9.
Yamaguchi, Y., Tsumura, H., Miwa, M. & Inaba, K. 1997. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15:144-53.
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T. & Storkus, W. J. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87-97.
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L. & Trono, D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-80.
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-5.
Zuo, Z., Wang, C., Carpenter, D., Okada, Y., Nicolaidou, E., Toyoda, M., Trento, A. & Jordan, S. C. 2001. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation 71:686-91.